Irinotecan and fatigue 
Irinotecan and fatigue Patient Reports February 12, 2012
Irinotecan Side Effects Report #4745852-0
Irinotecan side effect was reported by a Health Professional from UNITED STATES on Aug 15, 2005. Male patient, 45 years of age, weighting 154.3 lb, was diagnosed with small intestine carcinoma metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: adenocarcinoma, exophthalmos, eye swelling, fatigue, headache
, hypercoagulation, malignant neoplasm progression, metastasis. Irinotecan dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL, COMPAZINE, DECADRON, ZOFRAN, MIRACLE MOUTHWASH, DILAUDID. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4561286-6
Irinotecan side effect was reported by a Health Professional from on Jan 10, 2005. Female patient, 86 years of age, weighting 147.0 lb, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: asthenia, eating disorder
, fatigue, fluid intake reduced, neutropenia, proctalgia, radiation injury, sepsis . Irinotecan dosage: 30 MG/M2 (WEEKLY X 6 WEEKS), INTRAVENOUS. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4545973-1
Irinotecan side effect was reported by a Consumer or non-health professional from on Dec 20, 2004. Female patient, 85 years of age, weighting 147.0 lb, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: asthenia, fatigue, oral intake reduced, post procedural pain, proctalgia. Irinotecan dosage: 30 MG/M*2 (WEEKLY X 6 WEEKS), INTRAVENOUS. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #4562885-8
Irinotecan side effect was reported by a Health Professional from on Jan 10, 2005. Male patient, 66 years of age, was diagnosed with prostate cancer
and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, fatigue, hyperphosphataemia, hyperuricaemia, hypocalcaemia, hypochromasia, metabolic acidosis, po2 decreased, renal failure acute. Irinotecan dosage: 180 MG/M*2 (CYCLIC; INTERVAL: ON DAY 1 EVERY 2 WEEKS) , INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CALCIUM FOLINATE. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #5094325-7
Irinotecan side effect was reported by a Health Professional from UNITED STATES on Aug 30, 2006. Female patient, weighting 114.6 lb, was diagnosed with oesophageal carcinoma and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, asthenia, dehydration, fatigue, incontinence, leukopenia, malnutrition, nausea
, neutrophil count abnormal. Irinotecan dosage: unknown. During the same period patient was treated with CISPLATIN, CETUXIMAB, MIRALAX, FOSAMAX, ATIVAN, CLINDAGEL, CLONAZEPAM. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #5056045-4
Irinotecan side effect was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2006. Male patient, weighting 233.7 lb, was diagnosed with glioblastoma multiforme and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: asthenia, blood test abnormal, convulsion, disease progression, fatigue, investigation abnormal, somnolence. Irinotecan dosage: 125MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, WELLBUTRIN, DECADRON, PROVIGIL, XANAX, PROTONIX. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5011283-1
Irinotecan side effect was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2006. Male patient, weighting 233.7 lb, was diagnosed with glioblastoma multiforme and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: convulsion, fatigue, laboratory test abnormal, somnolence. Irinotecan dosage: 125 MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, WELLBUTRIN, DECADRON SRC, PROVIGIL, XANAX, PROTONIX. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5017537-7
Irinotecan side effect was reported by a Consumer or non-health professional from UNITED STATES on June 01, 2006. Female patient, weighting 125.9 lb, was diagnosed with glioblastoma multiforme and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: brain herniation, depressed level of consciousness, fatigue, pyrexia, respiratory arrest, somnolence. Irinotecan dosage: 325MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, DILANTIN, PEPCID, DECADRON, FLORINEF. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5017894-1
Irinotecan side effect was reported by a Consumer or non-health professional from UNITED STATES on June 02, 2006. Female patient, weighting 125.9 lb, was diagnosed with glioblastoma multiforme and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: aphasia
, brain herniation, computerised tomogram abnormal, condition aggravated, depressed level of consciousness, fatigue, pyrexia, respiratory arrest, somnolence. Irinotecan dosage: 325MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, DILANTIN, PEPCID, DECADRON, FLORINEF, MICARDIS, HUMALOG, LANTUS. Patient died on 05/31/2006.Irinotecan Side Effects Report #4692264-4
Irinotecan side effect was reported by a Physician from on June 02, 2005. Female patient, 69 years of age, was diagnosed with gastric cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, dizziness
, fatigue, malaise, oedema, oedema peripheral. Irinotecan dosage: 106 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with TEGAFUR. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4699648-9
Irinotecan side effect was reported by a Physician from on June 10, 2005. Female patient, 69 years of age, was diagnosed with gastric cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, dizziness
, fatigue, malaise, oedema peripheral. Irinotecan dosage: 106 MG INTERMITTENT, INTRAVENOUS. During the same period patient was treated with TEGAFUR, MUCOSTA, GASMOTIN, ENZYMES, AMINOFLUID, GLYCERIN, HALCION. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4709503-3
Irinotecan side effect was reported by a Physician from JAPAN on June 23, 2005. Female patient, 69 years of age, was diagnosed with gastric cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, dizziness
, fatigue, malaise, oedema peripheral. Irinotecan dosage: unknown. During the same period patient was treated with IRINOTECAN HYDROCHLORIDE SOLUTION, TEGAFUR, INTRALIPID, MUCOSTA, GASMOTIN, ENZYMES, AMINOFLUID. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4663840-X
Irinotecan side effect was reported by a Physician from on May 03, 2005. Female patient, 44 years of age, was diagnosed with gastric cancer, adenocarcinoma and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: fatigue, leukopenia, multi-organ failure, neutropenia, post procedural diarrhoea, post procedural nausea, post procedural vomiting. Irinotecan dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM. Patient died.
Irinotecan Side Effects Report #5200411-0
Irinotecan side effect was reported by a Consumer or non-health professional from JAPAN on Dec 26, 2006. Female patient was diagnosed with gastric cancer, nutritional support
, dyspepsia and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, aspartate aminotransferase increased, back pain , blood albumin decreased, diarrhoea, dizziness , eye discharge, fatigue, haemoglobin decreased. Irinotecan dosage: DAILY DOSE:80MG/M*2-FREQ:INTERMITTENT. During the same period patient was treated with TEGAFUR, INTRALIPID, MUCOSTA, GASMOTIN, ENZYMES. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4712363-8
Irinotecan side effect was reported by a Physician from CANADA on June 28, 2005. Male patient, 75 years of age, weighting 163.1 lb, was diagnosed with colorectal cancer metastatic, metastases to liver and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: abdominal pain lower, clostridial infection, decreased appetite, diarrhoea, fatigue, hypokalaemia, small intestinal perforation, vertigo, vomiting. Irinotecan dosage: 180 MG/M2 (1 IN 2 WK), INTRAVENOUS. During the same period patient was treated with LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, FLUOROURACIL, TYLENOL, LOPERAMIDE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #4765217-5
Irinotecan side effect was reported by a Physician from CANADA on Aug 24, 2005. Male patient, 75 years of age, weighting 163.1 lb, was diagnosed with colorectal cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: ascites, bacteria stool identified, clostridial infection, decreased appetite, diarrhoea, fatigue, hypokalaemia, small intestinal perforation, vertigo. Irinotecan dosage: 180 MG/M2 (1 IN 2 WK), INTRAVENOUS. During the same period patient was treated with LEUCOVORIN CALCIUM, FLUOROURACIL, TYLENOL, LOPERAMIDE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #4777880-3
Irinotecan side effect was reported by a Physician from ITALY on Sept 08, 2005. Male patient, 70 years of age, was diagnosed with colorectal cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: fatigue. Irinotecan dosage: unknown. Patient was hospitalized. Patient died on 08/10/2005.
Irinotecan Side Effects Report #4635750-5
Irinotecan side effect was reported by a Physician from on Mar 31, 2005. Male patient, 62 years of age, weighting 176.4 lb, was diagnosed with colorectal cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: apathy, dizziness
, fatigue, pruritus, rash pustular, somnolence, visual disturbance. Irinotecan dosage: 160 MG (WK), INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ATROPINE. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #5154527-8
Irinotecan side effect was reported by a Consumer or non-health professional from GERMANY on Feb 10, 1998. Male patient, 59 years of age, was diagnosed with colorectal cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, back pain
, cardiac disorder, constipation , fatigue, hyperhidrosis, hypertension, peripheral coldness. Irinotecan dosage: 350 MG/M*2 (EVERY 3 WEEKS), INTRAVENOUS. During the same period patient was treated with PROSTAGUTT. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #5406508-4
Irinotecan side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2007. Female patient, 56 years of age, was diagnosed with colorectal cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: abdominal infection, abdominal pain lower, acute respiratory distress syndrome, ascites, asthenia, decubitus ulcer, fatigue, fistula
, hypotension. Irinotecan dosage: DAILY DOSE:240MG-FREQ:FREQUENCY: ONCE EVERY 2 WEEKS. During the same period patient was treated with CETUXIMAB, DIPHENHYDRAMINE HYDROCHLORIDE, PALONOSETRON, DEXAMETHASONE. Patient was hospitalized. Patient died.Irinotecan Side Effects Report #5411569-2
Irinotecan side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2007. Female patient, 56 years of age, was diagnosed with colorectal cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: abdominal infection, abdominal pain lower, acute respiratory distress syndrome, ascites, asthenia, decubitus ulcer, fatigue, fistula
, hypotension. Irinotecan dosage: DAILY DOSE:240MG-FREQ:FREQUENCY: ONCE EVERY 2 WEEKS. During the same period patient was treated with CETUXIMAB, DIPHENHYDRAMINE HYDROCHLORIDE, PALONOSETRON, DEXAMETHASONE. Patient was hospitalized. Patient died.Irinotecan Side Effects Report #6023816-7
Irinotecan side effect was reported by a Health Professional from CANADA on Dec 17, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: asthenia, dehydration, diarrhoea, dyspnoea, fatigue, feeling cold, gait disturbance. Irinotecan dosage: 350 MG ON DAY 1 EVERY 3 WEEKS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, AVASTIN, NORVASC, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, ASPIRIN, NABILONE, ZOFRAN. Patient died on 12/14/2008.
Irinotecan Side Effects Report #5128742-3
Irinotecan side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 29, 2006. Male patient, weighting 240.0 lb, was diagnosed with colon cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: fatigue, haemoglobin decreased, insomnia, red blood cell count decreased, unevaluable event. Irinotecan dosage: 150 MG (150 MG). During the same period patient was treated with ATROPINE, ALLOPURINOL, ASPIRIN, PLAVIX, TRIAMTERENE, SIMVASTATIN, INSULIN. Patient recovered.
Irinotecan Side Effects Report #5177584-1
Irinotecan side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 28, 2006. Male patient, weighting 240.0 lb, was diagnosed with colon cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, haemoglobin decreased, immobile, red blood cell count decreased. Irinotecan dosage: 150 MG (150 MG), INTRAVENOUS. During the same period patient was treated with ATROPINE, ALLOPURINOL, ASPIRIN, PLAVIX, TRIAMTERENE, SIMVASTATIN, INSULIN. Patient recovered.
Irinotecan Side Effects Report #4893404-4
Irinotecan side effect was reported by a Physician from UNITED STATES on Jan 25, 2006. Female patient, weighting 15.21 lb, was diagnosed with central nervous system neoplasm and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: abnormal behaviour, central nervous system neoplasm, computerised tomogram abnormal, convulsion, disease recurrence, fatigue, headache
, malignant neoplasm progression, nodule. Irinotecan dosage: unknown. During the same period patient was treated with TEMOZOLOMIDE, VINCRISTINE, CEFIXIME CHEWABLE. Patient died on 01/16/2006.Irinotecan Side Effects Report #4880334-7
Irinotecan side effect was reported by a Physician from UNITED STATES on Dec 30, 2005. Male patient, 71 years of age, weighting 176.4 lb, was diagnosed with ill-defined disorder and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, fatigue, febrile neutropenia, hypomagnesaemia, pneumonia
, thrombocytopenia. Irinotecan dosage: 100 MG/M2 (CYCLICAL), INTRAVENOUS. During the same period patient was treated with NEUPOGEN, VITAMIN, VITAMIN C, VITAMIN B12, PRIMATENE MIST, ALEVE, EXCEDRIN, DECADRON. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4624402-3
Irinotecan side effect was reported by a Health Professional from on Mar 30, 2005. Female patient, 61 years of age, weighting 205.0 lb, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: ageusia, bronchitis
, diarrhoea, fatigue, febrile neutropenia, nausea , pancytopenia, pneumonia , productive cough. Irinotecan dosage: 120 MG QD INTRAVENOU. During the same period patient was treated with CISPLATIN, ZOLPIDEM TARTRATE, HYDROCODONE, GUAFENESIN, ALBUTEROL, CLINDAMYCIN, CEFEPIME, GEMFIBROZIL. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #5295728-8
Irinotecan side effect was reported by a Health Professional from UNITED STATES on Apr 10, 2007. Female patient, weighting 123.0 lb, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, vomiting. Irinotecan dosage: 150MG/M2 D 1 Q21 IV. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #4675917-3
Irinotecan side effect was reported by a Consumer or non-health professional from on May 26, 2005. Male patient, weighting 200.2 lb, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: blood culture positive, dyspnoea exertional, fatigue, haemoglobin decreased, neutrophil count decreased, oxygen saturation decreased, pulmonary embolism
, pyrexia, red blood cell count decreased. Irinotecan dosage: 50 MG/M2 IV DAYS 1 + 8, OVER 90 MINS. During the same period patient was treated with CISPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4847091-1
Irinotecan side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 05, 2005. Male patient, weighting 240.3 lb, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, dysgeusia, dyspnoea exertional, fatigue, weight decreased. Irinotecan dosage: unknown. During the same period patient was treated with CISPLATIN, ETOPOSIDE. Patient died.